| X23-10-ZQ373 |
JAK inhibitor Decernotinib, Purity ≥98%
|
|
| X23-10-ZQ374 |
JAK inhibitor Delgocitinib, Purity ≥98%
|
|
| X23-10-ZQ375 |
JAK inhibitor Filgotinib, Purity ≥98%
|
|
| X23-10-ZQ376 |
JAK inhibitor FLLL32, Purity ≥98%
|
|
| X23-10-ZQ377 |
JAK inhibitor FM-381, Purity ≥98%
|
|
| X23-10-ZQ378 |
JAK inhibitor GLPG0634, Purity ≥98%
|
|
| X23-10-ZQ380 |
JAK inhibitor Gusacitinib, Purity ≥98%
|
|
| X23-10-ZQ381 |
JAK inhibitor Ruxolitinib, Purity ≥98%
|
|
| X23-10-ZQ382 |
JAK inhibitor Itacitinib, Purity ≥98%
|
|
| X23-10-ZQ383 |
JAK inhibitor JAK-IN-1, Purity ≥98%
|
|
| X23-10-ZQ384 |
JAK inhibitor JAK-IN-3, Purity ≥98%
|
|
| X23-10-ZQ385 |
JAK inhibitor JAK-IN-4, Purity ≥98%
|
|
| X23-10-ZQ386 |
JAK inhibitor JAK-IN-5, Purity ≥98%
|
|
| X23-10-ZQ387 |
JAK inhibitor JAK1-IN-3, Purity ≥98%
|
|
| X23-10-ZQ388 |
JAK inhibitor JAK1-IN-4, Purity ≥98%
|
|
| X23-10-ZQ389 |
JAK inhibitor JAK1-IN-7, Purity ≥98%
|
|
| X23-10-ZQ390 |
JAK inhibitor JAK2-IN-4, Purity ≥98%
|
|
| X23-10-ZQ391 |
JAK3 covalent inhibitor-1, Purity ≥98%
|
|
| X23-10-ZQ392 |
JAK inhibitor JAK3-IN-1, Purity ≥98%
|
|
| X23-10-ZQ393 |
JAK inhibitor JAK3-IN-2, Purity ≥98%
|
|
